Publications:

Predictive mutation signature of immunotherapy benefits in NSCLC based on machine learning algorithms.

Frontiers In Immunology

Liu, Zhichao Z; Lin, Guo G; Yan, Zeping Z; Li, Linduo L; Wu, Xingchen X; Shi, Jingrong J; He, Jianxing J; Zhao, Lei L; Liang, Hengrui H; Wang, Wei W

Publication Date: 2022

Variant appearance in text: PTEN: 685T>G; S229A

PubMed Link: 36238300

Variant Present in the following documents:

• Table_1.xlsx, sheet 4

View BVdb publication page

EPHA5 mutation was associated with adverse outcome of atezolizumab treatment in late-stage non-small cell lung cancers.

Bmc Pulmonary Medicine

Li, Zhenxiang Z; Zhou, Qing Q; Wang, Qi Q; Wang, Haiyong H; Yue, Weiming W

Publication Date: 2022-09-19

Variant appearance in text: PTEN: 685T>G; S229A

PubMed Link: 36123678

Variant Present in the following documents:

• 12890_2022_2161_MOESM2_ESM.xlsx, sheet 1

View BVdb publication page

A phosphorylation switch controls the spatiotemporal activation of Rho GTPases in directional cell migration.

Nature Communications

Cao, Xuan X; Kaneko, Tomonori T; Li, Jenny S JS; Liu, An-Dong AD; Voss, Courtney C; Li, Shawn S C SS

Publication Date: 2015-07-13

Variant appearance in text: PTEN: S229A

PubMed Link: 26166433

Variant Present in the following documents:

• Main text
• ncomms8721-s1.pdf
• ncomms8721.pdf

View BVdb publication page

Insights into the complexity and functionality of hepatitis C virus NS5A phosphorylation.

Journal Of Virology

Ross-Thriepland, Douglas D; Harris, Mark M

Publication Date: 2014-02

Variant appearance in text: PTEN: S229A

PubMed Link: 24257600

Variant Present in the following documents:

• Main text
• zjv1421.pdf

View BVdb publication page